Dwight A. Bellinger

5.9k citations
81 papers · 4.7k · h-index 35

Impact in

  • Hematology top 0.5%
    • Hemophilia Treatment and Research
    • Platelet Disorders and Treatments
    • Blood Coagulation and Thrombosis Mechanisms
  • Genetics top 0.5%
    • Virus-based gene therapy research

Papers in

  • Hematology 30
    • Platelet Disorders and Treatments 19
    • Hemophilia Treatment and Research 13
    • Blood groups and transfusion 7
    • Blood Coagulation and Thrombosis Mechanisms 7
  • Genetics 28
    • Virus-based gene therapy research 25
Co-authors
Timothy C. Nichols (53 shared papers)Marjorie S. Read (20 shared papers)Katherine A. High (8 shared papers)Mark A. Kay (5 shared papers)Kenneth M. Brinkhous (4 shared papers)Elizabeth P. Merricks (20 shared papers)Roland W. Herzog (5 shared papers)Arthur R. Thompson (3 shared papers)
Journals
Blood (8 papers)Proceedings of the National Academy of Sciences (6 papers)Human Gene Therapy (4 papers)PLoS ONE (3 papers)Arteriosclerosis Thrombosis and Vascular Biology (3 papers)
Partner nations
United StatesChinaIndia

In The Last Decade

Dwight A. Bellinger

75 papers receiving 4.5k citations

Peers

Dwight A. Bellinger
Comparison fields: 5 of 109
  • Hematology 1.1k
  • Genetics 2.5k
  • Oncology 1.1k
  • Molecular Biology 2.2k
  • Periodontics 115
Replace Gordon F. Burns with:
Gordon F. Burns Australia
Bénédicte Dubois Belgium
Timothy S. Olson United States
Maria Wiekowski United States
Iqbal S. Grewal United States
Donna D. Strong United States
David N. Posnett United States
E Grosshans France
J L Cordell United Kingdom
Charles R. Maliszewski United States
Dwight A. Bellinger relative to Gordon F. Burns Australia Gordon F. Burns's profile →
Citations per field
00.5×2×4×5.8×
Gordon F. Burns · 1×
Citations per year

Countries citing papers authored by Dwight A. Bellinger

Since Specialization
Citations

This map shows the geographic impact of Dwight A. Bellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dwight A. Bellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dwight A. Bellinger more than expected).

Fields of papers citing papers by Dwight A. Bellinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dwight A. Bellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dwight A. Bellinger. The network helps show where Dwight A. Bellinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Dwight A. Bellinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dwight A. Bellinger Line = papers co-authored together Dwight A. Bellinger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
Nature Medicine ·Roland W. Herzog, Edmund Y. Yang, Linda B. Couto, J. Nathan Hagstrom, Dan Elwell, Paul Fields, Melissa Burton, Dwight A. Bellinger, Marjorie S. Read, Kenneth M. Brinkhous, Gregory M. Podsakoff, Timothy C. Nichols, Gary J. Kurtzman, Katherine A. High
1999452
2
Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors
Nature Medicine ·Richard O. Snyder, Carol H. Miao, Leonard Meuse, Julie Tubb, Brian A. Donahue, Hui-Feng Lin, Darrel W. Stafford, Salil D. Patel, Arthur R. Thompson, Timothy C. Nichols, Marjorie S. Read, Dwight A. Bellinger, Kenneth M. Brinkhous, Mark A. Kay
1999339
3
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy
Blood ·Jane Mount, Roland W. Herzog, D. Michael Tillson, Susan Goodman, Nancy Robinson, Mark L. McCleland, Dwight A. Bellinger, Timothy C. Nichols, Valder R. Arruda, Clinton D. Lothrop, Katherine A. High
2002282
4
In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient Dogs
Science ·Mark A. Kay, Steven Rothenberg, Charles N. Landen, Dwight A. Bellinger, Frances E. Leland, Carol Toman, Milton J. Finegold, Arthur R. Thompson, Marjorie S. Read, Kenneth M. Brinkhous, Savio L.C. Woo
1993249
5
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.
Proceedings of the National Academy of Sciences ·Mark A. Kay, Charles N. Landen, S R Rothenberg, L A Taylor, Frances E. Leland, Sandra Wiehle, B Fang, Dwight A. Bellinger, Milton J. Finegold, Arthur R. Thompson
1994216
6
Porphyromonas gingivalis Bacteremia Induces Coronary and Aortic Atherosclerosis in Normocholesterolemic and Hypercholesterolemic Pigs
Arteriosclerosis Thrombosis and Vascular Biology ·Nadine Brodala, Elizabeth P. Merricks, Dwight A. Bellinger, Damrong Damrongsri, Steven Offenbacher, James D. Beck, Phoebus Madianos, Daniela Sotres, Yu‐Ling Chang, Gary G. Koch, Timothy C. Nichols
2005154
7
Sustained Expression of Therapeutic Level of Factor IX in Hemophilia B Dogs by AAV-Mediated Gene Therapy in Liver
Molecular Therapy ·Lili Wang, Timothy C. Nichols, Marjorie S. Read, Dwight A. Bellinger, Inder M. Verma
2000148
8
Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy
Blood ·Lili Wang, Roberto Calcedo, Timothy C. Nichols, Dwight A. Bellinger, Aaron Dillow, Inder M. Verma, James M. Wilson
2005146
9
Proteasome inhibition ablates activation of NF-κB in myocardial reperfusion and reduces reperfusion injury
American Journal of Physiology-Heart and Circulatory Physiology ·Joseph Pye, Farhad Ardeshirpour, Arlene S. McCain, Dwight A. Bellinger, Elizabeth P. Merricks, Julian Adams, Peter J. Elliott, Christine Pien, Thomas Fischer, Albert S. Baldwin, Timothy C. Nichols
2003145
10
Swine Models of Type 2 Diabetes Mellitus: Insulin Resistance, Glucose Tolerance, and Cardiovascular Complications
ILAR Journal ·Dwight A. Bellinger, E. P. Merricks, T. C. Nichols
2006141
11
Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene Therapy
Human Gene Therapy ·Roland W. Herzog, Paul Fields, Valder R. Arruda, Jeff O. Brubaker, Elina Armstrong, Darryl McClintock, Dwight A. Bellinger, Linda B. Couto, Timothy C. Nichols, Katherine A. High
2002125
12
Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion.
Proceedings of the National Academy of Sciences ·Marjorie S. Read, Robert L. Reddick, Arthur P. Bode, Dwight A. Bellinger, Timothy C. Nichols, Kirk A. Taylor, S V Smith, Deborah K. McMahon, Thomas R. Griggs, K. M. Brinkhous
199599
13
Gene Therapy for Hemophilia B: Host Immunosuppression Prolongs the Therapeutic Effect of Adenovirus-Mediated Factor IX Expression
Human Gene Therapy ·B Fang, Randy C. Eisensmith, H. Wang, Mark A. Kay, Ryan Cross, Charles N. Landen, Gary Gordon, Dwight A. Bellinger, Marjorie S. Read, Peisheng Hu, K. M. Brinkhous, Savio L.C. Woo
199598
14
Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A
Nature Communications ·Lily M. Du, Paquita Nurden, Alan T. Nurden, Timothy C. Nichols, Dwight A. Bellinger, Eric S. Jensen, Sandra L. Haberichter, Elizabeth P. Merricks, Robin A. Raymer, Juan Fang, Sevasti B. Koukouritaki, Paula M. Jacobi, Troy Hawkins, Kenneth Cornetta, Qizhen Shi, David A. Wilcox
201393
15
Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs.
PubMed ·Bingliang Fang, Heming Wang, Gerald W. Gordon, Dwight A. Bellinger, Marjorie S. Read, K. M. Brinkhous, Savio L.C. Woo, Randy C. Eisensmith
199689
16
Long-Term Efficacy of Adeno-Associated Virus Serotypes 8 and 9 in Hemophilia A Dogs and Mice
Human Gene Therapy ·Rita Sarkar, Melinda Mucci, Sankar Addya, Renee Tetreault, Dwight A. Bellinger, Timothy C. Nichols, Haig H. Kazazian
200688
17
Persistent expression of canine factor IX in hemophilia B canines
Gene Therapy ·Hengjun Chao, R. Jude Samulski, Dwight A. Bellinger, Paul E. Monahan, Timothy C. Nichols, (unknown)
199987
18
Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B
Blood ·Valder R. Arruda, Hansell H. Stedman, Virginia Haurigot, George Buchlis, Stefano Baila, Patricia Favaro, Yifeng Chen, Helen G Franck, Shangzhen Zhou, J. Fraser Wright, Linda B. Couto, Haiyan Jiang, Glenn F. Pierce, Dwight A. Bellinger, Federico Mingozzi, Timothy C. Nichols, Katherine A. High
201085
19
Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor.
Proceedings of the National Academy of Sciences ·Dwight A. Bellinger, Timothy C. Nichols, Marjorie S. Read, R L Reddick, M. A. Lamb, K. M. Brinkhous, B. L. Evatt, Thomas R. Griggs
198783
20
Neonatal or hepatocyte growth factor–potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B
Blood ·Lingfei Xu, Cuihua Gao, Mark S. Sands, Shirong Cai, Timothy C. Nichols, Dwight A. Bellinger, Robin A. Raymer, Stephanie McCorquodale, Katherine P. Ponder
200381

About Dwight A. Bellinger

Dwight A. Bellinger is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Immunology, having authored 81 papers that have together received 4.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (25 papers), Platelet Disorders and Treatments (19 papers), CAR-T cell therapy research (14 papers), Hemophilia Treatment and Research (13 papers), Viral Infectious Diseases and Gene Expression in Insects (10 papers), Blood groups and transfusion (7 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Blood properties and coagulation (5 papers). The work is most often cited by research in Hematology (1.1k citations), Genetics (2.5k citations), Oncology (1.1k citations), Molecular Biology (2.2k citations) and Periodontics (115 citations). Dwight A. Bellinger has collaborated with scholars based in United States, China and India. Frequent co-authors include Timothy C. Nichols, Marjorie S. Read, Katherine A. High, Mark A. Kay, Kenneth M. Brinkhous, Elizabeth P. Merricks, Roland W. Herzog, Arthur R. Thompson, Thomas R. Griggs and Charles N. Landen. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Human Gene Therapy, PLoS ONE and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gordon F. BurnsBreakdown of academic impact, for papers by Bénédicte DuboisBreakdown of academic impact, for papers by Timothy S. OlsonBreakdown of academic impact, for papers by Maria WiekowskiBreakdown of academic impact, for papers by Iqbal S. GrewalBreakdown of academic impact, for papers by Donna D. StrongBreakdown of academic impact, for papers by David N. PosnettBreakdown of academic impact, for papers by E GrosshansBreakdown of academic impact, for papers by J L CordellBreakdown of academic impact, for papers by Charles R. Maliszewski